Na Hae Ri, Cho Sung Tae
Department of Neurology, Bobath Memorial Hospital, Seongnam, Korea.
Department of Urology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Dement Neurocogn Disord. 2020 Sep;19(3):77-85. doi: 10.12779/dnd.2020.19.3.77.
Lower urinary tract dysfunction (LUTD) is a common health challenge in dementia patients with significant morbidity and socioeconomic burden. It often causes lower urinary tract (LUT) symptoms, restricts activities of daily life, and impairs quality of life. Among several LUT symptoms, urinary incontinence (UI) is the most prominent storage symptom in the later stages of dementia. UI in patients with dementia results not only from cognitive impairment, but also from urological defects such as detrusor overactivity. Management of LUTD in patients with dementia is based on multiple factors, including cognitive state, functional impairment, concurrent comorbidities, polypharmacy and urologic condition. Behavioral therapy under caregiver support represents appropriate treatment strategy for UI in these patients. Pharmacological treatment can be considered in patients refractory to behavioral therapy, but it is more effective when combined with behavioral therapy. Antimuscarinics and mirabegron, a beta-3 receptor agonist, are effective for managing storage symptoms involving the LUT. However, anticholinergic side effects in elderly subjects are a concern, particularly when there is a risk of exacerbating cognitive impairment with prolonged use of antimuscarinics. Proper recognition and treatment of LUTD in dementia can improve quality of life in these patients.
下尿路功能障碍(LUTD)是痴呆症患者常见的健康挑战,具有较高的发病率和社会经济负担。它常导致下尿路(LUT)症状,限制日常生活活动,并损害生活质量。在几种LUT症状中,尿失禁(UI)是痴呆症后期最突出的储尿期症状。痴呆症患者的UI不仅源于认知障碍,还源于诸如逼尿肌过度活动等泌尿系统缺陷。痴呆症患者LUTD的管理基于多种因素,包括认知状态、功能损害、并发疾病、多重用药情况和泌尿系统状况。在护理人员支持下的行为疗法是这些患者UI的合适治疗策略。对行为疗法难治的患者可考虑药物治疗,但与行为疗法联合使用时更有效。抗胆碱能药物和β-3受体激动剂米拉贝隆对管理涉及LUT的储尿期症状有效。然而,老年患者的抗胆碱能副作用令人担忧,尤其是当长期使用抗胆碱能药物有加重认知障碍风险时。正确识别和治疗痴呆症患者的LUTD可改善这些患者的生活质量。